Financial Advisory Service, Inc. Abbott Laboratories Transaction History

Financial Advisory Service, Inc.

$1.18 Billion
Q3 2024

A detailed history of Financial Advisory Service, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 5,396 shares of ABT stock, worth $641,854. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,396

Previous 5,236 3.06%

Holding current value

$641,854

Previous $544,000 13.05%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$100.07 - $118.13 $16,011 - $18,900	160 Added 3.06%	5,396 $615,000
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $3,525 - $3,935	35 Added 0.67%	5,236 $544,000
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $3,942 - $4,354	-36 Reduced 0.69%	5,201 $591,000
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $22,276 - $27,268	247 Added 4.95%	5,237 $576,000
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $476,694 - $571,953	4,990 New	4,990 $483,000
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $3,390 - $3,990	35 Added 0.75%	4,692 $475,000
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $5,418 - $6,356	-57 Reduced 1.21%	4,657 $511,000
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $1,838 - $2,128	-19 Reduced 0.4%	4,714 $456,000
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $104,213 - $125,960	1,021 Added 27.51%	4,733 $514,000
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $15,734 - $19,187	-138 Reduced 3.58%	3,712 $439,000
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $3,581 - $4,385	31 Added 0.81%	3,850 $542,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $53,663 - $59,367	460 Added 13.69%	3,819 $451,000
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $4,125 - $4,856	39 Added 1.17%	3,359 $389,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $7,945 - $9,360	73 Added 2.25%	3,320 $398,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $525 - $572	5 Added 0.15%	3,247 $356,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $458 - $556	5 Added 0.15%	3,242 $353,000
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $1,684 - $2,156	-22 Reduced 0.68%	3,237 $296,000
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $13,506 - $19,749	215 Added 7.06%	3,259 $257,000
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $8,400 - $9,351	-107 Reduced 3.4%	3,044 $264,000
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $27,498 - $29,816	336 Added 11.94%	3,151 $264,000
Q2 2019 Jul 25, 2019	SELL	$72.88 - $85.0 $10,713 - $12,495	-147 Reduced 4.96%	2,815 $237,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $2,185 - $2,641	33 Added 1.13%	2,962 $237,000
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $23,273 - $26,365	-355 Reduced 10.81%	2,929 $212,000
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $304 - $366	5 Added 0.15%	3,284 $241,000
Q2 2018 Jul 26, 2018	BUY	$57.57 - $63.54 $188,772 - $208,347	3,279 New	3,279 $200,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.

Account

Financial Advisory Service, Inc. Abbott Laboratories Transaction History